International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY
|
|
|
- Hilary Matthews
- 6 years ago
- Views:
Transcription
1 International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY A Joint Initiative of IAEA BELNUC - JULES BORDET INSTITUTE OCTOBER 2-6, 2017 Venue: Auditorium Tagnon Jules Bordet Institute Boulevard de Waterloo BRUSSELS BELGIUM 1
2 MONDAY October 2, :00-9:30 AM Pre-Course knowledge evaluation IAEA participants - Multiple Choice Questions 9:30-10:00 AM Welcome by the 3 hosts: Patrick FLAMEN (Institut Jules Bordet, IJB, Brussels) Christophe DE ROOSE (BELNUC) Rodolfo NUNEZ MILLER (IAEA, Vienna) 10:00-10:45 AM Theranostics Richard BAUM (Zentralklinik Bad Berka, Germany) 10:45 AM Coffee Break 11:00-12:30 PM Basic Aspects: Nuclear Medicine and Theranostics: - Physical Bases: which isotopes? Silvano GNESIN (CHUV, Lausanne) - Radiopharmacy Zéna WIMANA (IJB, Brussels) - Radiobiology of Radionuclide Therapy Sarah BAATOUT (SCK, UZ Ghent) 2:00-2:45 PM Targeted Radionuclide Therapy using Alpha Emitting Radioisotopes Michael ZALUTSKY (Duke Univ., U.S.A.) 2: PM Discussion 3:00 PM Coffee Break 3:15-4:30 PM Regulatory Aspects: new tracer developments - Regulatory aspects: Radiopharmacy (GMP) Guy BORMANS (KUL, Leuven) - Regulatory aspects: European Directives Marleen VAN DE CAPELLE (FANC, Brussels) 5:00 PM OPENING RECEPTION Cafeteria of Institut Jules Bordet 2
3 TUESDAY October 3, 2017 Neuroendocrine Tumors 9:00-10:30 AM - Oncology of NET to be confirmed - Molecular Imaging of NET Christophe DE ROOSE (KUL, Leuven) - PRRT in Management of NET Ioannis KARFIS (IJB, Brussels) 10:30 AM Coffee Break 11:00-12:00 AM Intra-arterial Treatments: - SIRT in Neuroendocrine Tumors Marnix LAM (UMC, Utrecht) - Intra-arterial Applications of PRRT Georgios LIMOURIS (NKUA, Athens) 12:00-12:30 PM Predicting Efficacy and Toxicity of PRRT to be confirmed 2:00-3:00 PM - Dosimetry Silvano GNESIN (CHUV, Lausanne) - Activity Quantification for Dosimetry Gwennaëlle MARIN (IJB, Brussels) 3:00-3:30 PM Radiopharmacy of SSTR targeted Theranostics Zéna WIMANA (IJB, Brussels) 3:30 PM Coffee Break 4:00 4:30 PM Neuroblastoma: MIBG Therapy Boudewijn BRANS (UZ, Ghent) 4:30-5:00 PM IAEA Nuclear Medicine Initiatives Rodolfo NUNEZ MILLER (IAEA, Austria) 3
4 WEDNESDAY October 4, 2017 Radio-embolisation Liver Tumors 9:00-10:30 AM 10:30 AM Coffee Break - SIRT in HCC Vincent DONCKIER (IJB, Brussels) - Oncology: SIRT in Colorectal Cancer Alain HENDLISZ (IJB, Brussels) - SIRT: State of the ART Marnix LAM (UMC Utrecht) 11:00-11:30 AM Interventional Radiology: Radiation lobectomy / Segmentectomy Michael VOUCHE (IJB, Brussels) 11:30-12:00 AM Resin vs Glass Microspheres: physical Aspects Stephan WALRAND (UCL, Brussels) 12:00-12:30 PM Predictive Dosimetry: BSA vs Partition Model Silvano GNESIN (CHUV, Lausanne) 2:00-2:30 PM Y90-PET vs Y90-Bremstrahlung SPECT Stephan WALRAND (UCL, Brussels) 2:30-3:00 PM Precision of pre-sirt predictive Dosimetry Hugo LEVILLAIN (IJB, Brussels) 3:00-3:30 PM Hepatic Scintigraphy for Liver Function reserve pre-sirt Marnix LAM (UMC Utrecht) 3:30 PM Coffee Break 4:00-4:30 PM How to organize a Clinical Theranostics Trial? Julie GAYE (IJB, Brussels) 4
5 Thursday October 5, 2017 Thyroid Cancer 9:00-10:30 AM 10:30 AM Coffee Break 11:00-12:30 PM - Current Guidelines related to I131-Therapy François JAMAR (UCL, Brussels) - Recurrent differentiated Thyroid Cancer: towards personalized Treatment based on Evaluation of Tumor Characteristics with PET Andreas BOCKISH (Essen Univ., Germany) - Oncology: new Developments in targeted Treatments Giuseppe COSTANTE (IJB, Brussels) - Dosimetry: Guidelines and Case Study Bruno VANDERLINDEN (IJB, Brussels) Silvano GNESIN (CHUV, Lausanne) - Dosimetry: clinical Considerations Pierre BOURGEOIS (IJB, Brussels) - Clinical Controversies / Round Table Discussion / Cases / Questions from the Audience Moderator: Rodrigo MORENO-REYES (Erasme Hospital, Brussels) 2:00-4:30 PM Theranostics Applications of radiolabeled Antibodies: - Radio-immunotherapy in Lymphoma to be confirmed - Radiopharmacy of Antibody Radiolabeling Zéna WIMANA (IJB, Brussels) - Use of radiolabeled Abs as Theranostics Liesbeth DE VRIES (UMCG, Groningen) - Radiolabeled Antibodies in Breast Cancer Géraldine GEBHART (IJB, Brussels) 6:00 PM MEET THE INDUSTRY tbc Hotel Manos, Brussels 8:00 PM CONGRESS DINNER Hotel Manos Restaurant, Brussels 5
6 FRIDAY October 6, 2017 Bone Metastasis 9:00-10:30 AM 10:30 11:00 AM Coffee Break :30 PM - Molecular Imaging of Bone Metastasis Hojjat AHMADZADEHFAR (University, Bonn) - B-emitting Radionuclides: Sr-Sm-Rh Francesco CICONE (Milano, Italy) - Multidisciplinary Treatment of Bone Metastasis to be confirmed - Alpha-emitting Radionuclides: Ra-223 to be confirmed - The Evolution of PSMA PET/CT Imaging with different Ligands, the Heidelberg Experience Frederik GIESEL (Heidelberg Univ., Germany) Prostate Cancer: 2:00-4:00 PM 4:00 PM Coffee Break - 68Ga PSMA versus 18F-PSMA PET/CT Imaging in Prostate Cancer Frederik GIESEL (Heidelberg University, Germany) - Molecular Imaging of Prostate Cancer Carlos ARTIGAS (IJB, Brussels) - PSMA targeted Radionuclide Therapy Hojjat AHMADZADEHFAR (Univ. Bonn) - Roundtable Discussion Moderator: Patrick FLAMEN (IJB, Brussels) 4:30-5:00 PM Post-Course Knowledge Evaluation IAEA-participants 5:00 PM CLOSING CEREMONY 6
12th Congress of the World Federation of Nuclear Medicine and Biology April 2018 TRACK: ONCOLOGY Melbourne Convention and Exhibition Centre
12th Congress of the World Federation of Nuclear Medicine and Biology 20-24 April 2018 TRACK: ONCOLOGY Melbourne Convention and Exhibition Centre Saturday 21 April 2018 30 Jan 18 10:30-12:00 ONCOLOGY 1
Theranostics in Nuclear Medicine
Theranostics in Nuclear Medicine Patrick FLAMEN, MD, PhD Head Nuclear Medicine Institut Jules Bordet Université Libre de Bruxelles (U.L.B.) n Theranostics in Nuclear Medicine n A form of (nuclear) diagnostic
BORDET DEPARTMENT RADIATION ONCOLOGY
BORDET DEPARTMENT RADIATION ONCOLOGY The Radiation Oncology Department has been providing patients with high quality, tailored radiation oncology care for the last 60 years in a multidisciplinary setting
First AUBMC Theranostics Conference: See What You Treat
The Division of Nuclear Medicine, PET/CT and Cyclotron Facilities, Department of Diagnostic Radiology, AUBMC presents the First AUBMC Theranostics Conference: See What You Treat Endorsed by the International
12th Congress of the World Federation of Nuclear Medicine and Biology April 2018 TRACK: ONCOLOGY Melbourne Convention and Exhibition Centre
12th Congress of the World Federation of Nuclear Medicine and Biology 20-24 April 2018 TRACK: ONCOLOGY Melbourne Convention and Exhibition Centre Saturday 21 April 2018 10:30-12:00 ONCOLOGY 1- PROSTATE
12th Congress of the World Federation of Nuclear Medicine and Biology April 2018 TRACK: ONCOLOGY Melbourne Convention and Exhibition Centre
12th Congress of the World Federation of Nuclear Medicine and Biology 20-24 April 2018 TRACK: ONCOLOGY Melbourne Convention and Exhibition Centre 7 Mar 18 Saturday 21 April 2018 10:30-12:00 ONCOLOGY 1
IAEA/RCA Regional Training Course on Theragnostics and Dementias
International Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health TN-RAS6083-1702276 IAEA/RCA Regional Training Course
International Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health
International Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health RAS6074 RAS6074 Improving Quality of Life of Cancer Patients
Regional Training Course on PET/CT in Oncology. (RER-6.035) PROGRAM
Regional Training Course on PET/CT in Oncology. (RER-6.035) Riga and Liepaja (Latvia), October 3rd- 6th, 2016 Venue: Nuclear Medicine Centre, Gardenes Street 13, Riga, LATVIA (NOTE: Learning objectives
IAEA/RCA Regional Training Course on Theragnostics and Dementias
International Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health TN-RAS6083-1702276 IAEA/RCA Regional Training Course
Workshop and Final Coordination Meeting on Nuclear Medicine Techniques in Neurological Diseases II (ICNMP-PA)
International Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health RAS6074 Improving Quality of Life of Cancer Patients
Physical Bases : Which Isotopes?
Physical Bases : Which Isotopes? S. Gnesin Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Switzerland 1/53 Theranostic Bruxelles, 2 Octobrer 2017 Theranostic : use of diagnostic
Precision of pre-sirt predictive dosimetry
International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY Precision of pre-sirt predictive dosimetry Hugo Levillain Department of Nuclear Medicine Medical Physics Jules Bordet Institute, Université
PROGRAMME OVERVIEW Saturday, October 13, 2018
Saturday, October 13, 2018 Plenary Hall Meeting Room 26 Hall 1 Hall 2 Hall 3 Hall X Hall Y Hall 28 - - - - - - - - - - Advisory Council Meeting Delegates Assembly 1 Radiopharmacy/ Drug Development Trial
Workshop and Final Coordination Meeting on Nuclear Medicine Techniques in Neurological Diseases II (ICNMP-PA)
International Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health RAS6074 Improving Quality of Life of Cancer Patients
3rd Human Cancer Immunology Course for Oncologists and Scientists A course for Clinicians and Investigators
Service de Médecine & Laboratoire d Investigation Clinique & d Oncologie Expérimentale : Pr Martine J. PICCART, Chef du Service de Médecine Centre des Tumeurs de l Université Libre de Bruxelles Tél. :
Beyond FDG: International Symposium on PET Tracers in Oncology
Second announcement Beyond FDG: International Symposium on PET Tracers in Oncology Presymposium workshop, April 2 nd Date April 3 rd and 4 th, 2014 Location University Medical Center Groningen, Groningen,
Friday 20 April 2018 Pre congress meetings
Programme Overview *7 March 2018 20-24 April 2018 Melbourne Convention and Exhibition Centre, Australia Friday 20 April 2018 Pre congress meetings * Room allocations are subject to change 0070 2030 Registration
SIRT in Neuroendocrine Tumors
SIRT in Neuroendocrine Tumors Marnix G.E.H. Lam, MD PhD Professor of Nuclear Medicine AVL Amsterdam UMC Utrecht ENETS Center of Excellence, The Netherlands Disclosure of speaker s interests Consultant
Friday 20 April Pre-congress meetings
Programme Overview *8th February 2018 Friday 20 April 2018 - Pre-congress meetings * Room allocations are subject to change 0070-2030 Registration open Exhibition Concourse, MCEC Room Plenary 2 Room 216
Friday 20 April Pre-congress meetings
Programme Overview *27th February 2018 12th Congress of the World Federation of Nuclear Medicine and Biology 20-24 April 2018 Melbourne Convention and Exhibition Centre, Australia Friday 20 April 2018
IAEA Regional Workshop on Understanding CT Scan Role in Hybrid Imaging (PET/CT and SPECT/CT)
International Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health WS-RAS6091-EVT1801548 IAEA Regional Workshop on Understanding
Friday 20 April pre-congress meetings
Programme Overview * 8 January 2018 12th Congress of the World Federation of Nuclear Medicine and Biology 20-24 April 2018 Melbourne Convention and Exhibition Centre, Australia Friday 20 April 2018 - pre-congress
Nuclear Medicine and Radiation Therapy. International Conference on. July 16-17, 2018 Madrid, Spain. Nuclear Meetings Medicine 2018.
Nuclear Meetings Medicine 2018 International International Conference on Nuclear Medicine and Radiation Therapy July 16-17, 2018 Madrid, Spain Theme: Tailoring precision diagnostics and therapy for improved
Net Cancer Day Webinar
Net Cancer Day Webinar The webinar will start shortly Please make sure to dial in using the numbers provided or in the upper right hand side of the screen select Switch to Interactive Meeting to enable
3. ITLT Essen 2013 Interdisciplinary Treatment of Liver Tumors April 18-20, 2013 Essen, Germany
3. ITLT Essen 2013 Interdisciplinary Treatment of Liver Tumors April 18-20, 2013 Essen, Germany Scientific Program Thursday, 18th April 2013 HR Thursday, 18th April 08:00 Breakfast Symposia 09:00 Registration
SARCOPHAGINE CHELATORS AND COPPER ISOTOPES FOR IMAGING AND THERAPY
SEEING IS BELIEVING SARCOPHAGINE CHELATORS AND COPPER ISOTOPES FOR IMAGING AND THERAPY Sydney Vital and STEaM Neuroendocrine Tumour Preceptorship May 2018 Amos Hedt Head of Clinical Development 1 CLARITY
+ Radioembolization for ColoRectal Cancer Metastatic to the Liver
+ Radioembolization for ColoRectal Cancer Metastatic to the Liver Oct 4 th 2017 Alain Hendlisz, Institut Jules Bordet 1 st International Course on THERANOSTICS & MOLECULAR RADIOTHERAPY Indication and Rationale
Lu-DOTATATE PRRT dosimetry:
177 Lu-DOTATATE PRRT dosimetry: From theory to practice Silvano Gnesin Medical Physics department Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Switzerland Gwennaëlle Marin Medical
2017 SNMMI Mid-Winter and ACNM Annual Meeting Arizona Grand Resort Phoenix, AZ
Grand Ballroom FI 7:30-10:00 am Thursday, January 19, 2017 Sierra Ballroom Welcome and Introductions from CSNM/SNMMI/ACNM Non-Nuclear Molecular Imaging, MR and Optical ACNM Oral Research Presentations
Molecular Imaging of Bone Metastasis Hojjat Ahmadzadehfar
Molecular Imaging of Bone Metastasis Hojjat Ahmadzadehfar Seite 1 Bone metastases Different tumors % 80 70 68% 73% 60 50 40 40% 35% 42% 36% 30 20 10 0 5% prostate bladder renal breast thyroid lung GI urological
SCIENTIFIC TIMETABLE SIOP 2015
SCIENTIFIC TIMETABLE SIOP 2015 September, 2015 WEDNESDAY, 7 TH OCTOBER 2015 / DAY 2 1.43 09:30 SIOP Committee 12:00 SIOP Essential Drugs Working 13:00 SIOP Work (Open) 14:00 Nurse Researchers 16:00 17:00
Quantitative Theranostics in Nuclear Medicine
Quantitative Theranostics in Nuclear Medicine M. Lassmann Klinik und Poliklinik für Nuklearmedizin Direktor: Prof. Dr. A. Buck Contents What is Theranostics? Potential Targets Basic Principles of Quantitative
Advanced quantification in oncology PET
Advanced quantification in oncology PET Irène Buvat IMNC UMR 8165 CNRS Paris 11 University Orsay, France buvat@imnc.in2p3.fr http://www.guillemet.org/irene ISSSMA 2013 - June 3rd 2013-1 Two steps Static
Workshop: Nuclear Medicine Techniques in Neurological Diseases: Emphasis on Oncology and Neurology (ICNMP-PA)
International Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health RAS6078 Strengthening Nuclear Medicine Applications through
FMU-ICRP Workshop on Radiological Protection in Medicine Current Status in Radionuclide Therapy Tuesday, October 3, 2017 Makoto Hosono, MD PhD Kindai
FMU-ICRP Workshop on Radiological Protection in Medicine Current Status in Radionuclide Therapy Tuesday, October 3, 2017 Makoto Hosono, MD PhD Kindai University Faculty of Medicine, Osaka, Japan Current
International Course on Theranostics and Molecular Radiotherapy ImmunoPET in Breast Cancer
International Course on Theranostics and Molecular Radiotherapy ImmunoPET in Breast Cancer Geraldine Gebhart Jules Bordet Institute 5/10/2017 PLAN OF THE TALK Increasing role of antibodies in anti-cancer
Workshop: Nuclear Medicine Techniques in Neurological Diseases: Emphasis on Oncology and Neurology (ICNMP-PA)*
International Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health RAS6078 Strengthening Nuclear Medicine Applications through
Innovations in cancer treatment
Innovations in cancer treatment Matthias D'Huyvetter In Vivo Cellular and Molecular Imaging (ICMI) lab, Vrije Universiteit Brussel 19-5-2015 Herhaling titel van presentatie 1 Disclosure Matthias D Huyvetter
Selective Internal Radiation Therapy (SIRT) in the multimodal approach to Hepatocellular Carcinoma
Selective Internal Radiation Therapy (SIRT) in the multimodal approach to Hepatocellular Carcinoma International Course on THERANOSTICS and MOLECULAR RADIOTHERAPY Brussels, 4 october 2017 Vincent Donckier
V MEDITERRANEAN WORKSHOP ON ADVANCED MOLECULAR IMAGING. Multi Modality and MultiParametric Imaging in Advancing HealthCare
V MEDITERRANEAN WORKSHOP ON ADVANCED MOLECULAR IMAGING Multi Modality and MultiParametric Imaging in Advancing HealthCare Pagina 2 Wednesday May 31 Welcome addresses (8.30 9.00) Introductory Session R.
RADIATION ONCOLOGY 3 RD ESO-ESTRO MASTERCLASS IN. 3-8 November 2012 Milan, Italy FIRST ANNOUNCEMENT
MASTERCLASS MILAN 03/11/12 3 RD ESO-ESTRO MASTERCLASS IN RADIATION ONCOLOGY 3-8 November 2012 Milan, Italy Chair: M. Baumann, DE - J. Bernier, CH - R. Orecchia, IT R. Pötter, AT FIRST ANNOUNCEMENT Aims
Objective. Assessment Question. I. Theranostics II. Classic Theranostic Agent
Up and Coming Research Radiopharmaceuticals Dao Le, Pharm.D, BCNP Director, Nuclear Medicine, Radiopharmacy University of Texas MD Anderson Cancer Center Objective I. Theranostics II. Classic Theranostic
CANM 2019 Annual Scientific Meeting Réunion annuelle de l ACMN 2019 February 7-10, 2019 / 7 au 10 février Hôtel Le Concorde Québec City
CANM 2019 Annual Scientific Meeting Réunion annuelle de l ACMN 2019 February 7-10, 2019 / 7 au 10 février 2019 Hôtel Le Concorde Québec City PO Box 4383, Station E, Ottawa, ON K1S 2LO Tel: 613-882-5097
Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain
CNIO Frontiers Meetings Primary and Secondary Brain Tumors 19th-22nd February 2017 Organisers: Richard Gilbertson CRUK Cambridge Institute, UK Michael Weller University Hospital Zurich, Switzerland Massimo
CLINICAL IMPLEMENTATION OF HYBRID IMAGING CLINICAL IMPLEMENTATION OF HYBRID IMAGING COMBINED IMAGING CLINICAL IMPLEMENTATION OF
HYBRID OBJECTIVES OF ADDING CT-SCANNING TO NM? CLINICAL IMPLEMENTATION OF François Jamar UCL, Brussels ABR-BVS Workshop, Antwerp, Feb. 18, 2011 HYBRID COMBINED COMBINED ( PET AND CT) In-WBC 111 In COMBINED
TUESDAY, 18th OCTOBER, 2016 / DAY -2
Legend: Keynote Educational PODC Symposium Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite Symposium SIOPe GA SIOP ABM Late
TUESDAY, 18th OCTOBER, 2016 / DAY -2. THE SPENCER HOTEL Hall A Hall B (St. Lukes Hospital)
Legend: Keynote Educational Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite SIOPe GA SIOP ABM Late Breaker Session Networking
Nuclear Medicine: Basics to therapy
Nuclear Medicine: Basics to therapy RCP Medical careers day Dr Sabina Dizdarevic MD MSc PhD FRCP Dr Deena Neriman MBBS FRCR Ms Charlotte Weston CEO BNMS On behalf of the British Nuclear Medicine Society
oncology For 9 th eso-esmo course on July 2012 ioannina, Greece
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA ioannina 21/07/12 9 th eso-esmo course on oncology For medical students 21-27 July 2012 ioannina, Greece chair: N. Pavlidis, GR core faculty: R.A. Audisio, UK
Y90 SIRT Therapy Dosimetric Aspects
Y90 SIRT Therapy Dosimetric Aspects David Chee-Eng Ng MBBS, BSc, MSc, MRCP, FAMS, FRCP (Edin) Head and Senior Consultant, Department of Nuclear Medicine and PET Singapore General Hospital Adjunct Assistant
June MISSOURI. Patient Education Day. Program
June 7 11 08 St. Louis, MISSOURI 2014 Patient Education Day Program Patient Education Day Agenda Sunday, June 8, 2014 10:00 10:15 am Welcome: SNmmI Patient advocacy advisory Board Chair Josh Mailman, President,
Expert Review The Role of Molecular Imaging in Response Prediction in Metastatic Breast Cancer
Expert Review The Role of Molecular Imaging in Response Prediction in Metastatic Breast Cancer Geraldine Gebhart, MD Institut Jules Bordet Brussels, Belgium Discussants Moderator Lee Lokey, MD prime Oncology
Radiobiology of radionuclide therapy
Radiobiology of radionuclide therapy Prof Sarah Baatout Sarah.Baatout@sckcen.be Head of the Radiobiology Unit, SCK CEN Faculty of Biosciences Engineering, Universiteit Gent, Belgium Faculté des Sciences,
Radionuclide Therapy: History, Present and Future Promise. History of Radionuclide (RN) Therapy. History of RN Therapy 8/2/2017
Radionuclide Therapy: History, Present and Future Promise Bennett S. Greenspan, MD, MS Professor, Dept. of Radiology, MCG / AU President, SNMMI AAPM Annual Meeting, Denver, CO History Symposium 8/02/2017
LYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH
LYON. FRANCE NOVEMBER 29-30 / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE https://events.easl.eu/eventportal/ Information/MLYON2013/HOME.aspx Abstract submission deadline:
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy Program Committee Martin Schuler, Essen (Chair) Cathrin Brisken,
PUBLICATION OF THE SUPERIOR HEALTH COUNCIL No Peptide Receptor Radionuclide Therapy
PUBLICATION OF THE SUPERIOR HEALTH COUNCIL No. 8838 Peptide Receptor Radionuclide Therapy In this scientific policy advisory report, the provides a risk assessment (efficacy, toxicity, safety and radioprotection)
08:00 Registration and distribution of conference material 09:30 10:00 OPENING CEREMONY
TUESDAY, 8 NOVEMBER 2011 08:00 Registration and distribution of conference material 09:30 10:00 OPENING CEREMONY M. Daud DDG NA, IAEA Opening Address K. Aning DDG TC, IAEA Opening Address R. K. Chhem DIR
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme 14-19 July 2016, Valencia, Spain Co-chairs: Andrés Cervantes, ES - Nicholas Pavlidis, GR - Susana Banerjee, UK Thursday, 14
Peptide Receptor Radionuclide Therapy using 177 Lu octreotate
Peptide Receptor Radionuclide Therapy using 177 Lu octreotate BLR Kam, Erasmus Medical Centre, Rotterdam DJ Kwekkeboom, Erasmus Medical Centre, Rotterdam Legal aspects As 177 Lu-[DOTA 0 -Tyr 3 ]octreotate
Ga68 Imaging. Roland HUSTINX Division of Nuclear Medicine and Oncologic Imaging Centre Hospitalier Universitaire de Liège Belgium
Ga68 Imaging Roland HUSTINX Division of Nuclear Medicine and Oncologic Imaging Centre Hospitalier Universitaire de Liège Belgium 68 Ga Produced by a 68 Ge/ 68 Ga generator Decays by positron emission
An International Atomic Energy Agency World Cancer Day Event A ROADMAP TO A CANCER-FREE WORLD. Programme. prevention diagnosis. *lymphoma cancer cell
An International Atomic Energy Agency World Cancer Day Event A ROADMAP TO A CANCER-FREE WORLD Programme prevention diagnosis quality assurance *lymphoma cancer cell treatment Friday 2 February 2018, From
Nuclear Medicine and PET. D. J. McMahon rev cewood
Nuclear Medicine and PET D. J. McMahon 150504 rev cewood 2018-02-15 Key Points Nuclear Medicine and PET: Imaging: Understand how Nuc Med & PET differ from Radiography & CT by the source of radiation. Be
Short Study Report for Health Authorities
the Active Title of the Study Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma Investigators & Study
ESTS SCHOOL FIRST ESTS-ERS COLLABORATIVE COURSE ON THORACIC ONCOLOGY A MULTIDISCIPLINARY UPDATE ON POTENTIALLY OPERABLE LUNG CANCER
SCHOOL FIRST -ERS COLLABORATIVE COURSE ON ONCOLOGY A MULTIDISCIPLINARY UPDATE ON POTENTIALLY OPERABLE LUNG CANCER 11-13 February 2019 Hamburg, Germany An application will be made for accreditation to European
Molecular Imaging Guided Therapy: The Perfect Storm. David M Schuster, MD Emory University Department of Radiology Atlanta, GA
Molecular Imaging Guided Therapy: The Perfect Storm David M Schuster, MD Emory University Department of Radiology Atlanta, GA Talk can be found at radiology.emory.edu Let s start with a case 74 year
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy Program Committee Ursula Klingmüller, Heidelberg (Chair)
Understanding Biological Activity to Inform Drug Development
National Cancer Policy Forum Understanding Biological Activity to Inform Drug Development December 12, 2016 Wolfgang Weber Molecular Imaging and Therapy Service Department of Radiology RECIST Response
Radioembolization with Lipiodol for the Treatment of Hepatocellular Carcinoma and Liver Metastases
Radioembolization with Lipiodol for the Treatment of Hepatocellular Carcinoma and Liver Metastases Pr Francesco Giammarile CHLS Lyon Faculté de Lyon Sud «Aut tace aut loquere meliora silentio» Malignant
Dosimetry and radiobiology for Peptide Receptor Radionuclide Therapy
Dosimetry and radiobiology for Peptide Receptor Radionuclide Therapy Short-ranged particle emitters for targeted radionuclide therapy require specific dosimetry and radiobiology Mark Konijnenberg Melodi
Nuclear Medicine in Australia. Shaun Jenkinson
Nuclear Medicine in Australia Shaun Jenkinson Landmark Infrastructure for Australian Science OPAL Research Reactor Australian Synchrotron Camperdown Cyclotron Bragg Institute Centre for Accelerator Science
International Conference on Clinical PET and Molecular Nuclear Medicine (IPET 2011)
IAEA-CN-185 International Conference on Clinical PET and Molecular Nuclear Medicine (IPET 2011) Trends in Clinical PET and Radiopharmaceutical Development 8 11 November 2011 Vienna, Austria Announcement
July 5 & 6, 2018, Paris SCIENTIFIC PROGRAM
www.paris-nash.org Dear Colleagues, We are delighted to announce the 4th Paris NASH Meeting to be held on July 5-6 th 2018. This international academic meeting is aimed to do a deep-dive into many aspects
WELCOME. is also available. OncoRay National Center for Radiation Research in Oncology, Dresden
OncoRay National Center for Radiation Research in Oncology, Dresden WELCOME Wifi: Network: UKD_Dozent Username: ukd-guest536 Password: mvhffjs3 is also available OncoRay National Center for Radiation Research
radiopharmaceuticals that greatly enhance their worldwide availability
International Conference on Clinical PET-CT and Molecular Imaging (IPET 2015) CN - 232 IAEA Headquarters - Vienna, Austria October 5-9, 2015 PRELIMINARY AGENDA Monday, 5 October 2015 REGISTRATION - OPENING
METROLOGY TO SUPPORT INNOVATION IN MOLECULAR RADIOTHERAPY. Glenn Flux
METROLOGY TO SUPPORT INNOVATION IN MOLECULAR RADIOTHERAPY Glenn Flux Head of Radioisotope Physics Royal Marsden Hospital & Institute of Cancer Research Sutton UK CGPM 2018 glenn.flux@icr.ac.uk Overview
Beyond FDG: International Symposium on PET Tracers in Oncology
Beyond FDG: International Symposium on PET Tracers in Oncology Presymposium workshop, April 2nd Date April 3rd and 4th, 2014 Location University Medical Center Groningen, Groningen, the Netherlands Information
PSMA Targeted radionuclide therapy in Prostate Cancer
PSMA Targeted radionuclide therapy in Prostate Cancer Tawatchai Chaiwatanarat Division of Nuclear Medicine Department of Radiology Chulalongkorn University Bangkok, Thailand * cell si ze ~20 µm Radionuclide
The impact of different radiation qualities on cancer cells
The impact of different radiation qualities on cancer cells Marjan Moreels, PhD Radiobiology Unit,, Belgium XXth Colloque GANIL Session 10, Amboise, France Oct 19, 2017 1 The Belgian Nuclear Research Center
Publishable Summary for 15HLT06 MRTDosimetry Metrology for clinical implementation of dosimetry in molecular radiotherapy
Publishable Summary for 15HLT06 MRTDosimetry Metrology for clinical implementation of dosimetry in molecular radiotherapy Overview The overall aim of this project is to provide the metrology for the clinical
PDX MODELS IN CLINICAL ONCOLOGY AND CANCER PRECISION MEDICINE 3-5 OCTOBER Seminar-Hotel Rigi am See Weggis Switzerland
PDX MODELS IN CLINICAL ONCOLOGY AND CANCER PRECISION MEDICINE 3-5 OCTOBER 2016 Seminar-Hotel Rigi am See Weggis Switzerland Scientific Programme Each speaker in the programme will be careful to allow enough
Belgian Society on Thrombosis and Haemostasis
BELGIAN SOCIETY Belgian Society on Thrombosis and Haemostasis Final Announcement ANNUAL MEETING 25-26 November 2010 Het Pand Gent Belgium Local organizer: Katrien Devreese Coagulation Laboratory - Ghent
Programme. "Quality Control Laboratories: How to Inspect" PIC/S Pre- Seminar and Seminar
PIC/S Pre- Seminar and Seminar "Quality Control Laboratories: How to Inspect" Programme Hosted by Taiwan Food and Drug Administration, Ministry of Health and Welfare 11-15 September 2017 Grand Victoria
Establishing and Expanding Nuclear Medicine Programes
Establishing and Expanding Nuclear Medicine Programes Dr. Rodolfo Núñez-Miller Nuclear Medicine and Diagnostic Imaging Section Division of Human Health IAEA Vienna (AUSTRIA). Outline Current Status of
Enhance Patient Care with Nuclear Medicine and Molecular Imaging
CONTINUING MEDICAL EDUCATION Department of Radiology and Radiological Science and the Present Enhance Patient Care with Nuclear Medicine and Molecular Imaging March 10-11, 2017 Johns Hopkins University
Third announcement. Joint FMU-ICRP Workshop on Radiological Protection in Medicine. Tuesday, October 3, 2017
ICRP ref: 4852-9144-9932 Third announcement Joint FMU-ICRP Workshop on Radiological Protection in Medicine Tuesday, October 3, 2017 Organised by Fukushima Medical University (FMU) and the International
Continual education in radiation. Welcome. Jan Bens
Continual education in radiation protection-highlights Welcome Jan Bens Continual education for occupational physicians. 2013: Wat te doen bij incidenten Comment réagir en cas d incidents? 2014: How to
8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC)
Sezione di Oncologia [ Meet the Professor ] 8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC) November 15-17, 2012 The Conference will include: 1) Lectures: Internationally recognized
Final Programme Autumn Congress Belgian Hand Group & Belgian Hand Therapists NERVE INJURIES IN THE UPPER EXTREMITY
Autumn Congress Belgian Hand Group & Belgian Hand Therapists NERVE INJURIES IN THE UPPER EXTREMITY Aula - Bank J.Van Breda & C, Antwerp Saturday, November 14th 2009 Final Programme www.hand.be Scientific
TIMETABLE. Monday, 10 June, 2019 EDUCATIONAL SESSIONS. Exchange Room 9 Exchange Room 10 Exchange Room 11. Exchange Room 4+5.
Educational Sessions TIMETABLE Opening / Closing Ceremony Educational Sessions Physics Sessions RTT Sessions (Education) Clinical Sessions Faculty RTT Sessions (Scientific) New Investigator Session Keynote
March 12-23, 2018 SCK CEN, Mol, Belgium. 09: h Welcome, SCK CEN film & Introduction Hans Vanmarcke, SCK CEN
Two-week training course on radiationinduced effects with particular emphasis on genetics, development, teratology, cognition as well as space-related health issues March 12-23, 2018, Mol, Belgium Preliminary
Radionuclides in Medical Imaging. Danielle Wilson
Radionuclides in Medical Imaging Danielle Wilson Outline Definitions History and development Radionuclide applications & techniques in imaging Conclusion Definition #1 : Radionuclide An unstable nucleus
GUIDELINE ON THE MANAGEMENT OF RECTAL CANCER
GUIDELINE ON THE MANAGEMENT OF RECTAL CANCER MARC PEETERS, ERIC VAN CUTSEM, DIDIER BIELEN, ALAIN BOLS, PIETER DEMETTER, ANDRÉ D HOORE, KARIN HAUSTERMANS, ALAIN HENDLISZ, ARNAUD LEMMERS, DANIEL LEONARD,
WORKSHOP ON NUCLEAR MOLECULAR IMAGING. sponsored by the IAEA
WORKSHOP ON NUCLEAR MOLECULAR IMAGING sponsored by the IAEA Campus Tecnológico e Nuclear Instituto Superior Técnico, Universidade de Lisboa 5 th - 6 th December 2016 1 AIM AND SCOPE This workshop brings
Optimization of a routine method for bone marrow dose estimation in
Optimization of a routine method for bone marrow dose estimation in 177 Lu-EDTMP therapy- Experience in Uruguay. Teran. M 1, Paolino.A 2, Coppe.F 2, Nuñez M 2, Hermida J C 2, Gaudiano.J 2 1 Cátedra de
THERANOSTICS MOLEKULARE BILDGEBUNG MITTELS PET/CT
THERANOSTICS MOLEKULARE BILDGEBUNG MITTELS PET/CT UND RADIOREZEPTORTHERAPIE VON NET Richard P. Baum Klinik für Molekulare Radiotherapie / Zentrum für Molekulare Bildgebung (PET/CT) ENETS Center of Excellence,
Molecular Imaging for Diagnosis and Prediction of Treatment Outcome
Payment Payment of the fee completes your registration. The symposium fee of 100,- should be paid before August 15, 2007, using one of the following methods: bank transfer to account number 92 91 12 539
Quantifying Y-90 PET. The Challenges Associated With the QUEST Study. Michael Tapner Research & Development Project Manager Sirtex
Quantifying Y-90 PET. The Challenges Associated With the QUEST Study Michael Tapner Research & Development Project Manager Sirtex Internal Dosimetry with 90 Y Resin Microspheres: QUEST COUNT MAP ACTIVITY